Faculty profile

Pierre Fiset

Back to faculty

Associate ProfessorDepartment of AnesthesiaMcGill University

Pierre Fiset

Associate Professor

Department of Anesthesia

Faculty of Medicine and Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
86 publications in the last five years, latest in 2026.
Senior (last) author on 7 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

224

Publications

6,790

Citations

439

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Other departments

Department of Pathology

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their McGill University profile.

Molecular pathology thoracic pathology

Latest papers

Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?
The Annals of thoracic surgery · 2026
Integrating Histologic Descriptors into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung Adenocarcinoma
medRxiv · 2026
Integrating Histologic Descriptors Into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung Adenocarcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2026

All 224 publications

Latest funding

Unlocking new options for patients with squamous cell carcinoma of the lung
CIHR · 2021 · Nominated PI
$60,000

All 1 grants and awards

From the 150 most recent of 224 publications.

Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?

Seitlinger J, Salko O, Bulgarelli Maqueda L, Meng A, Têtu M, Desilets A, Owen S, Shieh B, Wong A, Ofiara L, Agulnik J, Fiset PO, Malo J, Blais N, Florescu M, Tehfe M, Ferraro P, Nasir B, Cools-Lartigue J, Najmeh S, Juneau D, Elkrief A, Ferri L, Routy B, Liberman M, Spicer JD

The Annals of thoracic surgery20265 citations

DOI: 10.1016/j.athoracsur.2025.09.051 PMID: 41167577

Integrating Histologic Descriptors into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung Adenocarcinoma

Hanie Abolfathi, Michael Maranda-Robitaille, Fabien Lamaze, Manal Kordahi, Victoria Saavedra Armero, Michèle Orain, Pierre Fiset, David Joubert, Patrice Desmeules, Andréanne Gagné, Yasushi Yatabe, Yohan Bossé, Philippe Joubert

medRxiv20262 citationsOpen Access

DOI: 10.64898/2026.02.17.26346481

Integrating Histologic Descriptors Into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung Adenocarcinoma.

Abolfathi H, Maranda-Robitaille M, Lamaze FC, Kordahi M, Armero VS, Orain M, Fiset PO, Joubert D, Desmeules P, Gagné A, Yatabe Y, Bossé Y, Joubert P

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer20261 citationsOpen Access

DOI: 10.1016/j.jtho.2026.103895 PMID: 42055159

Perioperative Avelumab and Chemotherapy for Gastroesophageal Adenocarcinoma: Long-Term Survival Outcomes.

Alcindor T, Tankel J, Fiset PO, Dehghani M, Bertos N, Mueller C, Cools-Lartigue J, Camilleri-Broet S, Ferri L

International journal of cancer2026Open Access

DOI: 10.1002/ijc.70749 PMID: 42750489

Long-term survival results of perioperative chemoimmunotherapy with DCF and avelumab in locally advanced gastro-esophageal adenocarcinoma.

Thierry Alcindor, James Tankel, Pierre-Olivier Fiset, Lorenzo Ferri

Journal of Clinical Oncology2026

DOI: 10.1200/jco.2026.44.16_suppl.4096

P1.085. Real-World Outcomes of Double Checkpoint Inhibition for MSI-H Gastroesophageal Adenocarcinoma

Luís Castro, Andrew Meng, Abirami Sharma, Mehrnoush Dehghani, Pierre-Olivier Fiset, Sara Soldera, Lorenzo Ferri

Diseases of the Esophagus2026Open Access

DOI: 10.1093/dote/doag077.233

Mesothelial Lesions of the Testis

Ajay Rajaram, Pierre Fiset, Fadi Brimo

Advances in Anatomic Pathology2026

DOI: 10.1097/pap.0000000000000525 PMID: 41582881

Predictors of Lymph Node Upstaging in Early-Stage Resectable EGFR-Mutant Non-Small Cell Lung Cancer

Gökce Yavuz, Riccardo Tajè, Océane Bélanger Garant, Mehrnoush Dehghani, Filippo Tommaso Gallina, Pierre Fiset, Simonetta Buglioni, Jonathan Cools-Lartigue, Paolo Visca, Mathieu C. Rousseau, Daniele Forcella, Lorenzo Ferri, Edoardo Mercadante, Jonathan D. Spicer, Sara Najmeh

SSRN Electronic Journal2026Open Access

DOI: 10.2139/ssrn.7175425

P1.111. The Presence of Signet Ring Cells Predicts Aggressive Chemotherapy Resistance in Esophageal Adenocarcinoma

Andrew Meng, Luis Santos Castro, Denia Hamidi, Adolfo De Motta Molina, Mehrnoush Dehghani, Jonathan Cools-Lartigue, Jonathan Spicer, Mathieu Rousseau, Sara Najmeh, Jamil Asselah, Sara Soldera, Pierre-Olivier Fiset, Greta Evaristo, Carmen Mueller, Lorenzo Ferri

Diseases of the Esophagus2026Open Access

DOI: 10.1093/dote/doag077.259

596 Mapping the Biomarker Landscape of Gastroesophageal Adenocarcinomas: Overlap of CLDN18.2, HER2, PD-L1, and MMR in Individual Patients

Miryam Al Nasir, Mina S. Farag, Haneen Baitalmal, Saba Alsaddah, Émilie Pichette, Victoria Marcus, Sara Victoria Soldera, L. Ferri, Pierre Fiset, Greta Evaristo

Laboratory Investigation2026

DOI: 10.1016/j.labinv.2025.104883

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Pierre Fiset

Research

Latest papers

Latest funding

Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?

Integrating Histologic Descriptors into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung Adenocarcinoma

Integrating Histologic Descriptors Into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung Adenocarcinoma.

Perioperative Avelumab and Chemotherapy for Gastroesophageal Adenocarcinoma: Long-Term Survival Outcomes.

Long-term survival results of perioperative chemoimmunotherapy with DCF and avelumab in locally advanced gastro-esophageal adenocarcinoma.

P1.085. Real-World Outcomes of Double Checkpoint Inhibition for MSI-H Gastroesophageal Adenocarcinoma

Mesothelial Lesions of the Testis

Predictors of Lymph Node Upstaging in Early-Stage Resectable EGFR-Mutant Non-Small Cell Lung Cancer

P1.111. The Presence of Signet Ring Cells Predicts Aggressive Chemotherapy Resistance in Esophageal Adenocarcinoma

596 Mapping the Biomarker Landscape of Gastroesophageal Adenocarcinomas: Overlap of CLDN18.2, HER2, PD-L1, and MMR in Individual Patients

Unlocking new options for patients with squamous cell carcinoma of the lung

Frequent collaborators

Lorenzo Ferri

Logan Walsh

Philippe Joubert

Jonathan Spicer

Daniela Quail

Mark Sorin

William Foulkes

Yohan Bossé

Bruce Mazer

Ming Tsao

Ming-Sound Tsao

Morag Park

Ciriaco Piccirillo

Arielle Elkrief

Peter Siegel

Nada Jabado

Robert Zatorre

Sidong Huang

Jacek Majewski

Denise Klein

Tereza Martinu

Gilles Plourde

Normand Blais

Gefei Qing

Emina Torlakovic

Richard Fraser

Christine Brezden-Masley

Matthew Cheung

Sylvain Houle

John Waldron

Ella Huszti

Jean Wong

Dale Brown

Jim Woodgett

Ebba Kurz

Mariana Foldvari

Susan Reid

Kévin Jao

Mustapha Tehfe

Sarah-Jeanne Pilon